Andersons, Inc. ANDE revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Andersons, Inc. reported revenue across 4 business segments; the largest, Specialty And Primary Nutrients, was $815M, 53.3% of the filed sum (+16.7% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Specialty And Primary Nutrients$815M53.3%+16.7% yoy
- Premium Ingredients$263M17.2%-22.1% yoy
- Propane And Fuels$242M15.8%+15.2% yoy
- Segment Reporting Reconciling Item Other$210M13.7%+34.4% yoy
Members sum to the consolidated $1.53B for this period.
- United States$8.43Bshare n/a+4.0% yoy
- Other countries$1.73Bshare n/a-23.1% yoy
- Canada$519Mshare n/a+0.3% yoy
- Mexico$334Mshare n/a-14.8% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Specialty And Primary Nutrients$385M69.3%+1.9% yoy
- Segment Reporting Reconciling Item Other$77.7M14.0%+45.7% yoy
- Premium Ingredients$60.1M10.8%-0.3% yoy
- Propane And Fuels$32.9M5.9%-25.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.